← Back to Clinical Trials
Recruiting NCT07262853

NCT07262853 Dual Executive Function Training Package

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07262853
Status Recruiting
Phase
Sponsor Education University of Hong Kong
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 288 participants
Start Date 2025-10-13
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 11 Years
Study Type INTERVENTIONAL
Interventions
Executive Function Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 288 participants in total. It began in 2025-10-13 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Executive function (EF) refers to the cognitive processes that enable goal-directed regulation of thoughts, emotions, and behaviours. Two interrelated domains are commonly distinguished: "cool" EF, which involves abstract cognitive processes, and "hot" EF, which involves regulation in emotionally or motivationally charged contexts. Children with special educational needs (SENs) frequently show difficulties across both domains, yet most interventions target one in isolation. The present study aims to evaluate the effectiveness of a dual EF training package for three of the most prevalent SENs groups: attention-deficit/hyperactivity disorder (ADHD), specific learning difficulties (SpLD), and autism spectrum disorder (ASD). A total of 288 primary school students aged 6-12 years with a diagnosis of ADHD, ASD, or SpLD will be recruited. Participants will be randomly assigned to either an intervention or waitlist control group, stratified by diagnosis. Each intervention group (n = 48) will receive the dual EF training programme, while corresponding waitlist controls (n = 48) will receive it after the study. Pre- and post-intervention assessments will include neuropsychological tests of EF, teacher- and parent-reported behavioural ratings, and measures of disability impact, school satisfaction, and social participation.

Eligibility Criteria

Inclusion Criteria: * aged between 6 and 11 years * studying at primary schools in HK * confirmed or suspected ADHD, ASD, or SpLD Exclusion Criteria: * received executive function training * comorbid conditions

Contact & Investigator

Central Contact

Kean Poon

✉ kean.poon@unsw.edu.au

📞 +61 2 9348 8143

Frequently Asked Questions

Who can join the NCT07262853 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 11 Years, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07262853 currently recruiting?

Yes, NCT07262853 is actively recruiting participants. Contact the research team at kean.poon@unsw.edu.au for enrollment information.

Where is the NCT07262853 trial being conducted?

This trial is being conducted at Tai Po, Hong Kong.

Who is sponsoring the NCT07262853 clinical trial?

NCT07262853 is sponsored by Education University of Hong Kong. The trial plans to enroll 288 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology